Chiral separation of methadone in exhaled breath condensate using capillary electrophoresis

2017 ◽  
Vol 9 (15) ◽  
pp. 2342-2350 ◽  
Author(s):  
Samin Hamidi ◽  
Maryam Khoubnasabjafari ◽  
Khalil Ansarin ◽  
Vahid Jouyban-Gharamaleki ◽  
Abolghasem Jouyban

Breath analysis is a potential and non-invasive tool for monitoring drugs levels and the status of respiratory or systemic disorders and attracted more attentions in recent years.

2021 ◽  
Vol 40 (4) ◽  
pp. S63
Author(s):  
E. Ibáñez-Martínez ◽  
M. López-Nogueroles ◽  
M. Alcoriza-Balaguer ◽  
I. Pérez ◽  
M. Roca-Marugán ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
A. Shoemark ◽  
R. Wilson

Bronchiectasis is characterised by neutrophilic bronchial inflammation. Direct measurement of lung inflammation would be useful to assess disease activity, guide need for treatment, and monitor response. The aim of this study was to test whether exhaled breath condensate (EBC) pH, a simple noninvasive test, provides a clinically useful measure of inflammation in the lungs of patients with bronchiectasis. 96 consecutively referred patients were studied when clinically stable, 20 followed up over two years, and a further 22 patients seen during an exacerbation. Subjects breathed tidally for 10 minutes into a condensing chamber (Ecoscreen, Erich Jaeger, Hoechberg, Germany). pH in EBC was measured immediately using a pH probe. In a representative group of 25 patients samples were deaerated with argon gas. This was to control for variations in pH ex vivo by removing CO2. EBC was acidic in bronchiectasis patients () compared to controls () and primary ciliary dyskinesia patients (). pH was related to lung volume but not disease severity. Repeated measures show EBC pH changes with symptoms. EBC is further acidified during an exacerbation of bronchiectasis (), this acidification persists following treatment (). EBC pH is not sufficiently sensitive or specific to monitor patients' health status or provide information to inform acute treatment decisions.


2012 ◽  
Vol 194 (2) ◽  
pp. 222-228 ◽  
Author(s):  
Virginie de Broucker ◽  
Sidi Mohamed Hassoun ◽  
Sébastien Hulo ◽  
Nathalie Chérot-Kornobis ◽  
Rémi Nevière ◽  
...  

2019 ◽  
Vol 8 (11) ◽  
pp. 1783 ◽  
Author(s):  
Valentina Agnese Ferraro ◽  
Stefania Zanconato ◽  
Eugenio Baraldi ◽  
Silvia Carraro

Background: In the context of the so-called unified airway theory, chronic rhinosinusitis (CRS) and asthma may coexist. The inflammation underlying these conditions can be studied through the aid of biomarkers. Main body: We described the main biological mediators that have been studied in pediatric CRS and asthma, and, according to the available literature, we reported their potential role in the diagnosis and management of these conditions. As for CRS, we discussed the studies that investigated nasal nitric oxide (nNO), pendrin, and periostin. As for asthma, we discussed the role of fractional exhaled nitric oxide (feNO), the role of periostin, and that of biological mediators measured in exhaled breath condensate (EBC) and exhaled air (volatile organic compounds, VOCs). Conclusion: Among non-invasive biomarkers, nNO seems the most informative in CRS and feNO in asthma. Other biological mediators seem promising, but further studies are needed before they can be applied in clinical practice.


2010 ◽  
Vol 4 (2/3) ◽  
pp. 293 ◽  
Author(s):  
S. Marta Almeida ◽  
Pedro M. Felix ◽  
Cristiana Franco ◽  
Maria Do Carmo Freitas ◽  
Luis Cerqueira Alves ◽  
...  

2021 ◽  
Vol 5 (1) ◽  
pp. 3-7
Author(s):  
Stephanos Patsiris ◽  
Grigoris Stelios ◽  
Ilias Papanikolaou ◽  
Themis Exarchos ◽  
Panayiotis Vlamos

Chronic obstructive pulmonary disease (COPD) is a respiratory disease with high prevalence. Many factors contribute to its development, and probably that leads to its various clinical pictures. Inflammation is the mechanism responsible for the structural alterations in the lungs. Despite its heterogeneity, there are a couple of primary symptoms characterizing it, which are chronic and productive cough and dyspnea. The understanding of dyspnea in COPD is based on theories deriving from the interaction of a network formed between the cardiorespiratory and the neuromuscular system and their receptors. Many factors contribute to its occurrence, making it complex and giving it a very subjective character for a person to perceive. Various methods are used to study COPD. Non-invasive ones seem to attract attention nowadays. One of them is the exhaled breath condensate. It is a biofluid with rich content, which can capture a picture of the pathological processes happening in the lungs. Its study has shown that some markers of inflammation and oxidative stress, such as 8-isoprostane and H2O2, are elevated and able to connect dyspnea and inflammation. Additionally, they seem to provide information of the ongoing inflammatory process in the lungs as well as a picture of the severity of the symptoms. This evidence may enhance the association of dyspnea with dysfunctional breathing. Despite these interesting findings, further research is necessary both in dyspnea and inflammation in COPD to clarify their mechanisms and connective pathways. The utility of non-invasive techniques such as the exhaled breath condensate could be of significant help, but its establishment in the medical field requires extra studies.


Sign in / Sign up

Export Citation Format

Share Document